Incyte (INCY) Accounts Payables (2010 - 2026)

Incyte (INCY) posted Accounts Payables of $228.6 million for Q1 2026, up 8.9% on a QoQ basis from $209.9 million in Q4 2025, and up 16.92% year-over-year from $195.5 million in Q1 2025.

Incyte (INCY) Accounts Payables (2010 - 2026) Analysis & Trends

Incyte's Accounts Payables history runs 17 years deep, the most recent figure standing at $228.6 million for Q1 2026.

  • Quarterly Accounts Payables rose 16.92% year-over-year to $228.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $228.6 million (up 16.92% YoY) and the FY2025 annual result came in at $209.9 million, up 6.32% from the prior year.
  • Accounts Payables was $228.6 million for Q1 2026 at Incyte, up from $209.9 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $277.5 million in Q4 2022 and bottomed at $55.6 million in Q1 2023.
  • A 5-year average of $175.5 million and a median of $171.9 million in 2025 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2023 — Accounts Payables tumbled 63.53% — and 2024, when it jumped 195.22%.
  • Incyte's Accounts Payables stood at $277.5 million in 2022, then slumped by 60.51% to $109.6 million in 2023, then jumped by 80.17% to $197.5 million in 2024, then advanced by 6.32% to $209.9 million in 2025, then grew by 8.9% to $228.6 million in 2026.
  • Business Quant data shows INCY's Accounts Payables at $228.6 million in Q1 2026, $209.9 million in Q4 2025, and $171.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 5.74 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 10.62 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 8.64 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 423.55 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 80.54 Mn
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn 228.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 228.62 Mn
Dec 31, 2025 209.94 Mn
Sep 30, 2025 171.93 Mn
Jun 30, 2025 241.09 Mn
Mar 31, 2025 195.54 Mn
Dec 31, 2024 197.47 Mn
Sep 30, 2024 178.71 Mn
Jun 30, 2024 148.17 Mn
Mar 31, 2024 164.24 Mn
Dec 31, 2023 109.60 Mn
Sep 30, 2023 139.41 Mn
Jun 30, 2023 155.54 Mn
Mar 31, 2023 55.63 Mn
Dec 31, 2022 277.55 Mn
Sep 30, 2022 163.18 Mn
Jun 30, 2022 194.77 Mn
Mar 31, 2022 152.55 Mn
Dec 31, 2021 172.11 Mn
Sep 30, 2021 114.51 Mn
Jun 30, 2021 122.10 Mn